Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Sampson | M | - | 3 years | |
| Andrew Peter Sandham | M | 69 |
Polyprox Therapeutics Ltd.
 Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom. | 5 years |
| Michael Anstey | M | 43 |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom. | 5 years |
| Christine Martin | M | - |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom. | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Luc Dochez | M | 49 |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | 3 years |
| Dominic Smethurst | M | 50 |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | 2 years |
| Mann Muhsin | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 5 | 71.43% |
| Canada | 2 | 28.57% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kevin Moulder
- Personal Network
